The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...

To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) ...

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate whether GSK’s shingles vaccine, Shingrix (zoster vaccine recombinant ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

A vaccine to fight dementia? It turns out there may already be one — shots that prevent painful shingles also appear to ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...